Syndecan-1 Expression Is Associated with Tumor Size and EGFR Expression in Colorectal Carcinoma: A Clinicopathological Study of 230 Cases
Authors:
Open Access
- 1 January 2015
- journal article
- Published by Ivyspring International Publisher in International Journal of Medical Sciences
- Vol. 12 (2) , 92-99
Abstract
Background: Syndecan-1 (SDC1) is reported to modulate several key processes of tumorigenesis and has variable expression in many cancers. To date, the cause of altered expression has not been elucidated. In this study, we compared SDC1 expression with various clinicopathological parameters and molecular markers to evaluate its clinical significance in colorectal carcinoma.Keywords
This publication has 30 references indexed in Scilit:
- Prognostic significance of syndecan-1 expression in squamous cell carcinoma of the tonsilInternational Journal of Clinical Oncology, 2013
- Prognostic and predictive factors in colorectal cancer.2012
- Molecular functions of syndecan-1 in diseaseMatrix Biology, 2012
- Syndecan-1 and Syndecan-4 Are Independent Indicators in Breast CarcinomaJournal of Histochemistry & Cytochemistry, 2011
- Clinical significance of syndecan-1 and versican expression in human epithelial ovarian cancerOncology Reports, 2010
- The signaling mechanisms of syndecan heparan sulfate proteoglycansCurrent Opinion in Cell Biology, 2009
- Association of loss of epithelial syndecan-1 with stage and local metastasis of colorectal adenocarcinomas: An immunohistochemical study of clinically annotated tumorsBMC Cancer, 2008
- Epithelial Syndecan-1 Expression Is Associated with Stage and Grade in Colorectal CancerOncology, 2005
- SyndecansCirculation Research, 2005
- Genetic Alterations during Colorectal-Tumor DevelopmentNew England Journal of Medicine, 1988